Research study Program year 2023 Source: CMS Open Payments

BI 754091 first in man dose escalation

Research payments

$339,171

31 payments

Through program year 2023, $339,171 in research payments was reported against BI 754091 first in man dose escalation, across 31 payments.

Paid by (largest first): Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharmaceuticals, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$60,461	5
2022	Research	$262,690	8
2021	Research	$165	1
2020	Research	$4,143	9
2019	Research	$11,713	8

Breakdown

Who paid Research payments · program years 2019–2023

Boehringer Ingelheim International GmbH $323,151 13 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $16,020 18 payments

Who received the money Research payments · program years 2019–2023

Florida Cancer Specialists Organisation paid for research $150,814 3 payments
Sarah Cannon Research Institute Drug Development Unit At Tennessee Oncology Organisation paid for research $125,147 3 payments
Karmanos Cancer Hospital Teaching hospital · MI $24,098 6 payments
Ut Md Anderson Cancer Center Teaching hospital · TX $12,134 3 payments
Ou Health Stephenson Cancer Center Organisation paid for research $10,406 3 payments
Florida Cancer Specialists Research Data Management Office Organisation paid for research $4,820 1 payment
Tennessee Oncology Admin Organisation paid for research $3,088 2 payments
Cedars Sinai Medcl Ctr Organisation paid for research $1,950 1 payment
Stephenson Cancer Center Pharmacy Services Organisation paid for research $1,664 2 payments
Florida Cancer Specialists Sarasota Cattlemen Organisation paid for research $1,620 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

7 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.